Canine Arthritis Treatment Market

Canine Arthritis Treatment Market Forecast and Outlook 2025 to 2035

The canine arthritis treatment market is projected to grow from USD 2.6 billion in 2025 to USD 3.9 billion by 2035, at a CAGR of 4.2%. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) will dominate with a 47.3% market share, while oral canine arthritis treatment will lead the route of administration segment with a 55.6% share.

October 23, 2025

333 pages

Healthcare

Animal Health Therapeutics

Sabyasachi Ghosh

Key Statistics

Industry Size (2025): USD 2.6 billion
Forecast (2035): USD 3.9 billion
CAGR: 4.2% (2025 to 2035)

Canine Arthritis Treatment Market Size and Share Forecast Outlook 2025 to 2035

The canine arthritis treatment market is experiencing robust growth. Rising awareness of pet health, increasing cases of osteoarthritis in aging dogs, and growing expenditure on veterinary care are driving market expansion. The market is being supported by improved diagnostic capabilities, the availability of advanced therapeutics, and the growing acceptance of preventive healthcare practices among pet owners.

Pharmaceutical innovation focusing on safety, efficacy, and long-term management has enhanced treatment outcomes and compliance. Demand is further supported by the increasing humanization of pets and the resulting prioritization of animal well-being. The future outlook remains positive as veterinary infrastructure strengthens, and new product pipelines introduce targeted therapies with fewer side effects.

Regulatory approvals for novel drug formulations and expanding distribution networks are also contributing to accessibility Collectively, these developments are expected to sustain steady market growth, strengthen brand positioning among key manufacturers, and support continued expansion of treatment adoption across global veterinary care settings.

Canine Arthritis Treatment Market Market Value Analysis

Quick Stats for Canine Arthritis Treatment Market

Canine Arthritis Treatment Market Industry Value (2025): USD 2.6 billion
Canine Arthritis Treatment Market Forecast Value (2035): USD 3.9 billion
Canine Arthritis Treatment Market Forecast CAGR: 4.2%
Leading Segment in Canine Arthritis Treatment Market in 2025: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (47.3%)
Key Growth Region in Canine Arthritis Treatment Market: North America, Asia-Pacific, Europe
Top Key Players in Canine Arthritis Treatment Market: Zoetis, Boehringer Ingelheim International GmbH, DAIICHI SANKYO COMPANY, LIMITED, Thorne, NUTRI-VET, American Regent, Inc., DSM, National hog farmer, Novasep, Bayer AG, Matsun Nutrition

Metric	Value
Canine Arthritis Treatment Market Estimated Value in (2025 E)	USD 2.6 billion
Canine Arthritis Treatment Market Forecast Value in (2035 F)	USD 3.9 billion
Forecast CAGR (2025 to 2035)	4.2%

Canine Arthritis Treatment Market Industry Value Analysis

Segmental Analysis

The market is segmented by Treatment, Route Of Administration, and Distribution Channel and region. By Treatment, the market is divided into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells, and Autologous Stem Cells. In terms of Route Of Administration, the market is classified into Oral Canine Arthritis Treatment and Injectable Canine Arthritis Treatment. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Drug Stores, and E-Commerce. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Treatment Segment

Canine Arthritis Treatment Market Analysis By Treatment

The non-steroidal anti-inflammatory drugs (NSAIDs) segment, accounting for 47.30% of the treatment category, has been leading due to its proven efficacy in pain relief and inflammation control. Its dominance is supported by broad clinical acceptance and consistent results in improving mobility and quality of life in arthritic dogs. Ease of administration and rapid onset of action have made NSAIDs a preferred first-line therapy among veterinarians.

Market share is being reinforced by ongoing research aimed at improving gastrointestinal and renal safety profiles. Manufacturers are focusing on extended-release formulations and combination therapies to enhance convenience and therapeutic outcomes.

Regulatory bodies have supported this segment through approvals of safer and more targeted NSAID variants As clinical adoption grows and awareness of early intervention increases, the NSAIDs category is expected to retain its leadership position, contributing significantly to revenue generation in the canine arthritis treatment market.

Insights into the Route of Administration Segment

Canine Arthritis Treatment Market Analysis By Route Of Administration

The oral canine arthritis treatment segment, representing 55.60% of the route of administration category, remains the dominant method due to its convenience, cost-effectiveness, and ease of use for pet owners. Widespread availability of oral tablets, chewables, and flavored formulations has improved compliance among both veterinarians and pet owners.

The segment’s performance is reinforced by consistent dosing accuracy and established efficacy across a wide range of NSAIDs and supplementary therapies. Demand is being sustained by increasing product innovation focused on palatable and long-acting oral formulations.

Veterinary recommendations favoring oral administration for long-term management are further enhancing market penetration With continuous advancements in pharmacokinetics and controlled-release technologies, oral treatments are expected to maintain their leading share, driving consistent growth throughout the forecast period.

Insights into the Distribution Channel Segment

Canine Arthritis Treatment Market Analysis By Distribution Channel

The veterinary hospitals and clinics segment, holding 61.40% of the distribution channel category, dominates due to its established role in providing professional diagnosis, prescription, and follow-up care. Centralized procurement systems and trusted veterinary expertise have enhanced product reliability and accessibility.

Pet owners increasingly rely on veterinary clinics for both diagnosis and medication sourcing, strengthening this channel’s influence. The segment benefits from integrated treatment support, direct consultations, and personalized therapy plans, which reinforce adherence and therapeutic outcomes.

Market growth is further supported by the global expansion of veterinary chains, increased investment in animal healthcare infrastructure, and ongoing training of veterinary professionals As awareness of chronic disease management in pets rises, veterinary hospitals and clinics are expected to remain the primary distribution hub, ensuring consistent product availability and long-term dominance within the market.

Key Market Drivers

The canine arthritis treatment industry generated a valuation of USD 2.1 billion in 2020. The market grew at a rate of 5.0% CAGR over five years, generating an additional USD 2.6 million in valuation by 2025.

This growth can be attributed to various factors:

Increased awareness among pet owners about the importance of arthritis management for their canine companions, leading to earlier diagnosis and treatment initiation
Advancements in veterinary pharmaceuticals, such as new pain management medications and joint supplements, provide more effective options for arthritis relief
Expansion of veterinary services offering specialized treatments like acupuncture, hydrotherapy, and physical therapy, improving access to comprehensive arthritis care for dogs
Growing demand for minimally invasive surgical procedures for arthritis treatment due to pet owners' desire for less invasive yet effective solutions
Rise in pet insurance coverage, allowing more pet owners to afford arthritis treatments for their dogs, driving increased utilization of veterinary services
Adoption of preventive healthcare measures to address arthritis risk factors early on, highlighting the importance of proactive management in maintaining canine joint health
Development of innovative technologies like regenerative medicine for arthritis treatment, promising novel approaches to alleviate joint pain and improve mobility in dogs
The aging pet population leading to a higher prevalence of arthritis cases, underscoring the need for ongoing advancements in arthritis management strategies
Increasing disposable income among pet owners, facilitating greater investment in advanced arthritis treatments, and enhancing the overall quality of care for arthritic dogs
Strong emphasis on improving the quality of life and mobility for arthritic dogs, driving demand for effective treatment options due to the evolving attitudes towards pets as valued family members.

Consumption Analysis of the Canine Arthritis Treatment Market

Sales of canine arthritis treatments are growing among veterinary professionals, veterinary technicians, and other staff members, who diagnose, prescribe, and administer arthritis treatments to dogs
Canine arthritis treatments are also experiencing increasing demand from pet owners who own dogs affected by arthritis and seek out treatments to improve their pets' comfort and quality of life
The growing adoption of canine arthritis treatments is also observed among et insurance companies that provide coverage for veterinary expenses and help pet owners afford necessary care for their arthritic dogs
Pet product retailers are also some of the largest consumer groups in this market. These entities seek arthritis treatments for their canine companions, providing access to medications, supplements, and other supportive products
Veterinary clinics and pet care facilities generate great demand for canine arthritis treatments. These entities utilize canine arthritis treatments to address joint pain and mobility issues in dogs under their care.

Hesitation Among Pet Owners to Slow Down the Market Growth for Canine Arthritis Treatments

The canine arthritis treatment market is anticipated to grow at a modest CAGR of 4.20% till 2035. This is attributed to several reasons:

Canine arthritis treatments, in most cases, are hindered due to limited access to affordable veterinary care in certain regions, especially the underdeveloped and developing parts of the world.
Some pet owners are hesitant to try new medications or therapies due to concerns regarding the safety and efficacy of certain arthritis treatments. This leads to potential gaps in treatment, slowing down the market.
Traditional pharmaceutical treatments for canine arthritis also face competition from alternative treatments such as physical therapy, acupuncture, and chiropractic care. This is significantly diverting the consumer base.
Limited awareness and education among pet owners about early intervention and long-term management of arthritis in dogs is resulting in delayed diagnosis. This is detrimental to the health of the pet, which has to undergo a lot of pain.

Category-wise Insights

Pet Owners are Increasingly Preferring NSAIDs for Canine Arthritis Treatments

The NSAIDs category is projected to hold the largest share of the canine arthritis treatment market in the year 2025. This segment holds the dominant market share, accounting for 72% of the global canine arthritis treatment market.

The demand for NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) has skyrocketed in the last few decades as they are considered highly effective in relieving pain and inflammation associated with canine arthritis.
Veterinary professionals are also prescribing NSAIDs due to their proven effectiveness and safety profile in managing arthritis symptoms in dogs. This has made NSAIDs the most sought-after treatment option for pet owners.

Attributes	Details
Drug Class	NSAIDs
Market Share	72.00%

Veterinary Professionals are Prescribing Oral Treatments for Canine Arthritis

The canine arthritis treatment market is also categorized by route of administration into oral and injectable canine arthritis treatment. The oral segment dominates the market with a share of 70% in 2025.

Pet owners, as well as veterinary professionals, are increasingly choosing oral treatments as they offer a convenient administration route for them. This allows for easy integration into a dog's daily routine.
The demand for oral routes in canine arthritis treatments is also surging as they provide flexibility in dosing and administration schedules. This minimizes the risk of complications associated with injectable therapies, such as injection site reactions.

Attributes	Details
Route of Administration	Oral
Market Share	70.00%

Country-wise Insights

The section provides an analysis of the canine arthritis treatment market by country, including India, Spain, Italy, Australia, and France. The table presents the CAGR for each country, indicating the expected growth of the market in that country through 2035.

Countries	CAGR
Spain	5.50%
India	5.30%
Italy	4.90%
Australia	4.70%
France	4.60%

Growing Awareness about Arthritis in Dogs is pushing the Demand for Treatments in India

India is expected to exhibit significant market growth over the forecast period. The Indian market for canine arthritis treatments is anticipated to grow at a CAGR of 5.30% through 2035.

The growing awareness among Indian pet owners about the significance of veterinary care, including arthritis management, is driving the demand for treatment options.
The emerging middle class in India with more disposable income to spend on pet healthcare, including arthritis treatments. This is significantly fuelling market growth in the country.

Pet Humanization Trend to Boost Market Growth in Spain

Spain is also one of the lucrative markets in the canine arthritis treatment industry. The Spanish market for canine arthritis treatments is anticipated to grow at a CAGR of 5.50% through 2035.

Spain is witnessing a trend of pet humanization, where dogs are considered valued family members. This has resulted in an increased investment in their healthcare, including arthritis treatment.
The pet insurance market in Spain is also experiencing a significant surge in the recent past. This has helped pet owners afford expensive treatments, like arthritis subsequently contributing to the growth of this market.

Significant Population of Aging Dogs in Italy to Augment Market Growth

Italy also is a promising market in the global canine arthritis treatment industry. Over the next ten years, the Italian demand for canine arthritis treatments is projected to rise at a 4.90% CAGR.

The changing lifestyles in Italy, with more people living in urban areas and smaller homes, have led to an increased focus on pet health. This is also one of the main drivers for the exponential growth of this market in the country.
Italy has a significant population of aging dogs. This has led to a higher prevalence of arthritis and, thus, an increased demand for canine treatments in the country.

Pet-friendly Policies to Shape the Future of Canine Arthritis Market in Australia

Australia is also one of the countries that is filled with potential in this market. The Australian canine arthritis treatment market is anticipated to retain its dominance by progressing at a growth rate of 4.70% till 2035.

Australia's outdoor lifestyle contributes to a high level of physical activity for dogs. This has increased the risk of arthritis and, thus, driving demand for canine arthritis treatment options in the country.
Australia also has considerable pet-friendly policies and regulations. This encourages a supportive environment for pet healthcare, including arthritis treatment.

High-standard Veterinary Care to Boost the Market Growth in France

France also exhibits a promising future in the global canine arthritis treatment market. The canine arthritis treatment market in France is anticipated to retain its dominance by progressing at a growth rate of 4.60% till 2035.

France is known for its high standard of veterinary care, with skilled professionals offering advanced arthritis treatment solutions for dogs. This is one of the main reasons for the country’s position in the global market.
France's pet-friendly culture, with dogs being considered integral members of many households, also drives demand for arthritis treatment options.

Competitive Landscape

Canine Arthritis Treatment Market Analysis By Company

Major companies and manufacturers in the canine arthritis treatment market, such as Boehringer Ingelheim International GmbH., DAIICHI SANKYO COMPANY, LIMITED, Thorne, NUTRI-VET, American Regent, Inc., DSM, etc., investing heavily in research and development to innovate new medications, supplements, and therapeutic approaches.

These companies are also expanding their distribution networks and partnerships with veterinary clinics, pet retailers, and online platforms to enhance the market reach and accessibility of their products to pet owners.

Recent Developments:

In January 2025, TVM introduced DogStem, Europe's inaugural licensed stem cell therapy for canine osteoarthritis. Clinical trials demonstrated its efficacy, with improvements in gait and orthopedic examination, and owners reported enhanced mobility and quality of life for their pets, lasting up to eighteen months.
In May 2020, Elanco launched Galliprant, a new treatment for canine osteoarthritis pain, in the UK. Galliprant, a piprant, targets the EP4 receptor, reducing pain and inflammation without affecting gastrointestinal and kidney functions, offering a promising solution for managing OA discomfort in dogs.
In February 2025, Rejuvenate Bio partnered with a leading animal health company to develop and commercialize groundbreaking gene therapy for canine osteoarthritis, aiming to address the condition's widespread prevalence and devastating consequences, potentially revolutionizing dog health.

Key Companies in the Market

Boehringer Ingelheim International GmbH
DAIICHI SANKYO COMPANY, LIMITED
Thorne
NUTRI-VET
American Regent, Inc.
DSM
Zoetis
National hog farmer
Novasep
Bayer AG
Matsun Nutrition

Key Coverage in the Canine arthritis treatment Industry Report

Demand Analysis for Canine Arthritis Management Injection
Key Mergers and Acquisitions in the Canine Arthritis Treatment Market
Best Canine Osteoarthritis Treatment in India
Demand Analysis for Canine Osteoarthritis Therapy
General Overview of Dog Arthritis Medication Side Effects

Canine arthritis treatment Market by Segmentation

By Treatment:
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Opioids
- Stem Cell Therapy
- Allogeneic Stem Cells
- Autologous Stem Cells
By Route of Administration:
- Oral Canine Arthritis Treatment
- Injectable Canine Arthritis Treatment
By Distribution Channel:
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- Drug Stores
- e-Commerce
By Region:
- North America
- Latin America
- Asia Pacific
- Middle East and Africa (MEA)
- Europe

Frequently Asked Questions

How big is the canine arthritis treatment market in 2025?

The global canine arthritis treatment market is estimated to be valued at USD 2.6 billion in 2025.

What will be the size of canine arthritis treatment market in 2035?

The market size for the canine arthritis treatment market is projected to reach USD 3.9 billion by 2035.

How much will be the canine arthritis treatment market growth between 2025 and 2035?

The canine arthritis treatment market is expected to grow at a 4.2% CAGR between 2025 and 2035.

What are the key product types in the canine arthritis treatment market?

The key product types in canine arthritis treatment market are non-steroidal anti-inflammatory drugs (nsaids), opioids, stem cell therapy, allogeneic stem cells and autologous stem cells.

Which route of administration segment to contribute significant share in the canine arthritis treatment market in 2025?

In terms of route of administration, oral canine arthritis treatment segment to command 55.6% share in the canine arthritis treatment market in 2025.

Table of Content

Executive Summary
- Global Market Outlook
- Demand-side Trends
- Supply-side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
Market Background
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunity
  - Trends
- Scenario Forecast
  - Demand in Optimistic Scenario
  - Demand in Likely Scenario
  - Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
Global Market Analysis 2020-2024 and Forecast, 2025-2035
- Historical Market Size Value (USD Mn) Analysis, 2020-2024
- Current and Future Market Size Value (USD Mn) Projections, 2025-2035
  - Y-o-Y Growth Trend Analysis
  - Absolute $ Opportunity Analysis
Global Market Pricing Analysis 2020-2024 and Forecast 2025-2035
Global Market Analysis 2020-2024 and Forecast 2025-2035, By Treatment
- Introduction / Key Findings
- Historical Market Size Value (USD Mn) Analysis By Treatment , 2020-2024
- Current and Future Market Size Value (USD Mn) Analysis and Forecast By Treatment , 2025-2035
  - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  - Opioids
  - Stem Cell Therapy
  - Allogeneic Stem Cells
  - Autologous Stem Cells
- Y-o-Y Growth Trend Analysis By Treatment , 2020-2024
- Absolute $ Opportunity Analysis By Treatment , 2025-2035
Global Market Analysis 2020-2024 and Forecast 2025-2035, By Route Of Administration
- Introduction / Key Findings
- Historical Market Size Value (USD Mn) Analysis By Route Of Administration, 2020-2024
- Current and Future Market Size Value (USD Mn) Analysis and Forecast By Route Of Administration, 2025-2035
  - Oral Canine Arthritis Treatment
  - Injectable Canine Arthritis Treatment
- Y-o-Y Growth Trend Analysis By Route Of Administration, 2020-2024
- Absolute $ Opportunity Analysis By Route Of Administration, 2025-2035
Global Market Analysis 2020-2024 and Forecast 2025-2035, By Distribution Channel
- Introduction / Key Findings
- Historical Market Size Value (USD Mn) Analysis By Distribution Channel, 2020-2024
- Current and Future Market Size Value (USD Mn) Analysis and Forecast By Distribution Channel, 2025-2035
  - Veterinary Hospitals & Clinics
  - Retail Pharmacies
  - Drug Stores
  - E-Commerce
- Y-o-Y Growth Trend Analysis By Distribution Channel, 2020-2024
- Absolute $ Opportunity Analysis By Distribution Channel, 2025-2035
Global Market Analysis 2020-2024 and Forecast 2025-2035, By Region
- Introduction
- Historical Market Size Value (USD Mn) Analysis By Region, 2020-2024
- Current Market Size Value (USD Mn) Analysis and Forecast By Region, 2025-2035
  - North America
  - Latin America
  - Western Europe
  - Eastern Europe
  - East Asia
  - South Asia and Pacific
  - Middle East & Africa
- Market Attractiveness Analysis By Region
North America Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) Forecast By Market Taxonomy, 2025-2035
  - By Country
    - USA
    - Canada
    - Mexico
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Market Attractiveness Analysis
  - By Country
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Key Takeaways
Latin America Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) Forecast By Market Taxonomy, 2025-2035
  - By Country
    - Brazil
    - Chile
    - Rest of Latin America
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Market Attractiveness Analysis
  - By Country
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Key Takeaways
Western Europe Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) Forecast By Market Taxonomy, 2025-2035
  - By Country
    - Germany
    - UK
    - Italy
    - Spain
    - France
    - Nordic
    - BENELUX
    - Rest of Western Europe
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Market Attractiveness Analysis
  - By Country
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Key Takeaways
Eastern Europe Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) Forecast By Market Taxonomy, 2025-2035
  - By Country
    - Russia
    - Poland
    - Hungary
    - Balkan & Baltic
    - Rest of Eastern Europe
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Market Attractiveness Analysis
  - By Country
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Key Takeaways
East Asia Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) Forecast By Market Taxonomy, 2025-2035
  - By Country
    - China
    - Japan
    - South Korea
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Market Attractiveness Analysis
  - By Country
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Key Takeaways
South Asia and Pacific Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) Forecast By Market Taxonomy, 2025-2035
  - By Country
    - India
    - ASEAN
    - Australia & New Zealand
    - Rest of South Asia and Pacific
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Market Attractiveness Analysis
  - By Country
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Key Takeaways
Middle East & Africa Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) Forecast By Market Taxonomy, 2025-2035
  - By Country
    - Kingdom of Saudi Arabia
    - Other GCC Countries
    - Turkiye
    - South Africa
    - Other African Union
    - Rest of Middle East & Africa
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Market Attractiveness Analysis
  - By Country
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
- Key Takeaways
Key Countries Market Analysis
- USA
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Canada
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Mexico
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Brazil
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Chile
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Germany
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- UK
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Italy
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Spain
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- France
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- India
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- ASEAN
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Australia & New Zealand
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- China
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Japan
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- South Korea
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Russia
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Poland
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Hungary
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Kingdom of Saudi Arabia
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- Turkiye
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
- South Africa
  - Pricing Analysis
  - Market Share Analysis, 2024
    - By Treatment
    - By Route Of Administration
    - By Distribution Channel
Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
  - By Regional
  - By Treatment
  - By Route Of Administration
  - By Distribution Channel
Competition Analysis
- Competition Deep Dive
  - Zoetis
    - Overview
    - Product Portfolio
    - Profitability by Market Segments (Product/Age /Sales Channel/Region)
    - Sales Footprint
    - Strategy Overview
      - Marketing Strategy
      - Product Strategy
      - Channel Strategy
  - Boehringer Ingelheim International GmbH
  - DAIICHI SANKYO COMPANY, LIMITED
  - Thorne
  - NUTRI-VET
  - American Regent, Inc.
  - DSM
  - National hog farmer
  - Novasep
  - Bayer AG
  - Matsun Nutrition
Assumptions & Acronyms Used
Research Methodology

List of Tables

Table 1: Global Market Value (USD Mn) Forecast by Region, 2020-2035
Table 2: Global Market Value (USD Mn) Forecast by Treatment , 2020-2035
Table 3: Global Market Value (USD Mn) Forecast by Route Of Administration, 2020-2035
Table 4: Global Market Value (USD Mn) Forecast by Distribution Channel, 2020-2035
Table 5: North America Market Value (USD Mn) Forecast by Country, 2020-2035
Table 6: North America Market Value (USD Mn) Forecast by Treatment , 2020-2035
Table 7: North America Market Value (USD Mn) Forecast by Route Of Administration, 2020-2035
Table 8: North America Market Value (USD Mn) Forecast by Distribution Channel, 2020-2035
Table 9: Latin America Market Value (USD Mn) Forecast by Country, 2020-2035
Table 10: Latin America Market Value (USD Mn) Forecast by Treatment , 2020-2035
Table 11: Latin America Market Value (USD Mn) Forecast by Route Of Administration, 2020-2035
Table 12: Latin America Market Value (USD Mn) Forecast by Distribution Channel, 2020-2035
Table 13: Western Europe Market Value (USD Mn) Forecast by Country, 2020-2035
Table 14: Western Europe Market Value (USD Mn) Forecast by Treatment , 2020-2035
Table 15: Western Europe Market Value (USD Mn) Forecast by Route Of Administration, 2020-2035
Table 16: Western Europe Market Value (USD Mn) Forecast by Distribution Channel, 2020-2035
Table 17: Eastern Europe Market Value (USD Mn) Forecast by Country, 2020-2035
Table 18: Eastern Europe Market Value (USD Mn) Forecast by Treatment , 2020-2035
Table 19: Eastern Europe Market Value (USD Mn) Forecast by Route Of Administration, 2020-2035
Table 20: Eastern Europe Market Value (USD Mn) Forecast by Distribution Channel, 2020-2035
Table 21: East Asia Market Value (USD Mn) Forecast by Country, 2020-2035
Table 22: East Asia Market Value (USD Mn) Forecast by Treatment , 2020-2035
Table 23: East Asia Market Value (USD Mn) Forecast by Route Of Administration, 2020-2035
Table 24: East Asia Market Value (USD Mn) Forecast by Distribution Channel, 2020-2035
Table 25: South Asia and Pacific Market Value (USD Mn) Forecast by Country, 2020-2035
Table 26: South Asia and Pacific Market Value (USD Mn) Forecast by Treatment , 2020-2035
Table 27: South Asia and Pacific Market Value (USD Mn) Forecast by Route Of Administration, 2020-2035
Table 28: South Asia and Pacific Market Value (USD Mn) Forecast by Distribution Channel, 2020-2035
Table 29: Middle East & Africa Market Value (USD Mn) Forecast by Country, 2020-2035
Table 30: Middle East & Africa Market Value (USD Mn) Forecast by Treatment , 2020-2035
Table 31: Middle East & Africa Market Value (USD Mn) Forecast by Route Of Administration, 2020-2035
Table 32: Middle East & Africa Market Value (USD Mn) Forecast by Distribution Channel, 2020-2035

List of Figures

Figure 1: Global Market Pricing Analysis
Figure 2: Global Market Value (USD Mn) Forecast 2020–2035
Figure 3: Global Market Value Share and BPS Analysis by Treatment , 2025 and 2035
Figure 4: Global Market Y-o-Y Growth Comparison by Treatment , 2025–2035
Figure 5: Global Market Attractiveness Analysis by Treatment
Figure 6: Global Market Value Share and BPS Analysis by Route Of Administration, 2025 and 2035
Figure 7: Global Market Y-o-Y Growth Comparison by Route Of Administration, 2025–2035
Figure 8: Global Market Attractiveness Analysis by Route Of Administration
Figure 9: Global Market Value Share and BPS Analysis by Distribution Channel, 2025 and 2035
Figure 10: Global Market Y-o-Y Growth Comparison by Distribution Channel, 2025–2035
Figure 11: Global Market Attractiveness Analysis by Distribution Channel
Figure 12: Global Market Value (USD Mn) Share and BPS Analysis by Region, 2025 and 2035
Figure 13: Global Market Y-o-Y Growth Comparison by Region, 2025–2035
Figure 14: Global Market Attractiveness Analysis by Region
Figure 15: North America Market Incremental Dollar Opportunity, 2025–2035
Figure 16: Latin America Market Incremental Dollar Opportunity, 2025–2035
Figure 17: Western Europe Market Incremental Dollar Opportunity, 2025–2035
Figure 18: Eastern Europe Market Incremental Dollar Opportunity, 2025–2035
Figure 19: East Asia Market Incremental Dollar Opportunity, 2025–2035
Figure 20: South Asia and Pacific Market Incremental Dollar Opportunity, 2025–2035
Figure 21: Middle East & Africa Market Incremental Dollar Opportunity, 2025–2035
Figure 22: North America Market Value Share and BPS Analysis by Country, 2025 and 2035
Figure 23: North America Market Value Share and BPS Analysis by Treatment , 2025 and 2035
Figure 24: North America Market Y-o-Y Growth Comparison by Treatment , 2025–2035
Figure 25: North America Market Attractiveness Analysis by Treatment
Figure 26: North America Market Value Share and BPS Analysis by Route Of Administration, 2025 and 2035
Figure 27: North America Market Y-o-Y Growth Comparison by Route Of Administration, 2025–2035
Figure 28: North America Market Attractiveness Analysis by Route Of Administration
Figure 29: North America Market Value Share and BPS Analysis by Distribution Channel, 2025 and 2035
Figure 30: North America Market Y-o-Y Growth Comparison by Distribution Channel, 2025–2035
Figure 31: North America Market Attractiveness Analysis by Distribution Channel
Figure 32: Latin America Market Value Share and BPS Analysis by Country, 2025 and 2035
Figure 33: Latin America Market Value Share and BPS Analysis by Treatment , 2025 and 2035
Figure 34: Latin America Market Y-o-Y Growth Comparison by Treatment , 2025–2035
Figure 35: Latin America Market Attractiveness Analysis by Treatment
Figure 36: Latin America Market Value Share and BPS Analysis by Route Of Administration, 2025 and 2035
Figure 37: Latin America Market Y-o-Y Growth Comparison by Route Of Administration, 2025–2035
Figure 38: Latin America Market Attractiveness Analysis by Route Of Administration
Figure 39: Latin America Market Value Share and BPS Analysis by Distribution Channel, 2025 and 2035
Figure 40: Latin America Market Y-o-Y Growth Comparison by Distribution Channel, 2025–2035
Figure 41: Latin America Market Attractiveness Analysis by Distribution Channel
Figure 42: Western Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
Figure 43: Western Europe Market Value Share and BPS Analysis by Treatment , 2025 and 2035
Figure 44: Western Europe Market Y-o-Y Growth Comparison by Treatment , 2025–2035
Figure 45: Western Europe Market Attractiveness Analysis by Treatment
Figure 46: Western Europe Market Value Share and BPS Analysis by Route Of Administration, 2025 and 2035
Figure 47: Western Europe Market Y-o-Y Growth Comparison by Route Of Administration, 2025–2035
Figure 48: Western Europe Market Attractiveness Analysis by Route Of Administration
Figure 49: Western Europe Market Value Share and BPS Analysis by Distribution Channel, 2025 and 2035
Figure 50: Western Europe Market Y-o-Y Growth Comparison by Distribution Channel, 2025–2035
Figure 51: Western Europe Market Attractiveness Analysis by Distribution Channel
Figure 52: Eastern Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
Figure 53: Eastern Europe Market Value Share and BPS Analysis by Treatment , 2025 and 2035
Figure 54: Eastern Europe Market Y-o-Y Growth Comparison by Treatment , 2025–2035
Figure 55: Eastern Europe Market Attractiveness Analysis by Treatment
Figure 56: Eastern Europe Market Value Share and BPS Analysis by Route Of Administration, 2025 and 2035
Figure 57: Eastern Europe Market Y-o-Y Growth Comparison by Route Of Administration, 2025–2035
Figure 58: Eastern Europe Market Attractiveness Analysis by Route Of Administration
Figure 59: Eastern Europe Market Value Share and BPS Analysis by Distribution Channel, 2025 and 2035
Figure 60: Eastern Europe Market Y-o-Y Growth Comparison by Distribution Channel, 2025–2035
Figure 61: Eastern Europe Market Attractiveness Analysis by Distribution Channel
Figure 62: East Asia Market Value Share and BPS Analysis by Country, 2025 and 2035
Figure 63: East Asia Market Value Share and BPS Analysis by Treatment , 2025 and 2035
Figure 64: East Asia Market Y-o-Y Growth Comparison by Treatment , 2025–2035
Figure 65: East Asia Market Attractiveness Analysis by Treatment
Figure 66: East Asia Market Value Share and BPS Analysis by Route Of Administration, 2025 and 2035
Figure 67: East Asia Market Y-o-Y Growth Comparison by Route Of Administration, 2025–2035
Figure 68: East Asia Market Attractiveness Analysis by Route Of Administration
Figure 69: East Asia Market Value Share and BPS Analysis by Distribution Channel, 2025 and 2035
Figure 70: East Asia Market Y-o-Y Growth Comparison by Distribution Channel, 2025–2035
Figure 71: East Asia Market Attractiveness Analysis by Distribution Channel
Figure 72: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2025 and 2035
Figure 73: South Asia and Pacific Market Value Share and BPS Analysis by Treatment , 2025 and 2035
Figure 74: South Asia and Pacific Market Y-o-Y Growth Comparison by Treatment , 2025–2035
Figure 75: South Asia and Pacific Market Attractiveness Analysis by Treatment
Figure 76: South Asia and Pacific Market Value Share and BPS Analysis by Route Of Administration, 2025 and 2035
Figure 77: South Asia and Pacific Market Y-o-Y Growth Comparison by Route Of Administration, 2025–2035
Figure 78: South Asia and Pacific Market Attractiveness Analysis by Route Of Administration
Figure 79: South Asia and Pacific Market Value Share and BPS Analysis by Distribution Channel, 2025 and 2035
Figure 80: South Asia and Pacific Market Y-o-Y Growth Comparison by Distribution Channel, 2025–2035
Figure 81: South Asia and Pacific Market Attractiveness Analysis by Distribution Channel
Figure 82: Middle East & Africa Market Value Share and BPS Analysis by Country, 2025 and 2035
Figure 83: Middle East & Africa Market Value Share and BPS Analysis by Treatment , 2025 and 2035
Figure 84: Middle East & Africa Market Y-o-Y Growth Comparison by Treatment , 2025–2035
Figure 85: Middle East & Africa Market Attractiveness Analysis by Treatment
Figure 86: Middle East & Africa Market Value Share and BPS Analysis by Route Of Administration, 2025 and 2035
Figure 87: Middle East & Africa Market Y-o-Y Growth Comparison by Route Of Administration, 2025–2035
Figure 88: Middle East & Africa Market Attractiveness Analysis by Route Of Administration
Figure 89: Middle East & Africa Market Value Share and BPS Analysis by Distribution Channel, 2025 and 2035
Figure 90: Middle East & Africa Market Y-o-Y Growth Comparison by Distribution Channel, 2025–2035
Figure 91: Middle East & Africa Market Attractiveness Analysis by Distribution Channel
Figure 92: Global Market – Tier Structure Analysis
Figure 93: Global Market – Company Share Analysis

Select license type

The Interactive Forecasting Dashboard

Beyond the Numbers
Turn insight into impact. See the dashboard KPIs.

MarketNgage - Online Data Platform

MarketNgage
Real-time data you trust. Dashboards you love. Pricing that works

Our Research Products

The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.